Back
Ultragenyx Pharmaceutical Stock Price Chart
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.38 | Sell |
| 20-day SMA: | 40.41 | Sell |
| 50-day SMA: | 41.94 | Sell |
| 200-day SMA: | 42.46 | Sell |
| 8-day EMA: | 39.76 | Sell |
| 20-day EMA: | 40.54 | Sell |
| 50-day EMA: | 42.03 | Sell |
| 200-day EMA: | 43.46 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.73 | Sell |
| Relative Strength Index (14 RSI): | 45.77 | Sell |
| Chaikin Money Flow: | 722527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.99 - 42.29) | Sell |
| Bollinger Bands (100): | (41.03 - 48.83) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 39.60 while RARE 8-day simple moving average is 40.38, which is a Sell signal.
- The stock price of RARE is 39.60 while Ultragenyx Pharmaceutical 20-day SMA is 40.41, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day simple moving average is 41.94 while RARE share price is 39.60, making it a Sell technically.
- RARE stock price is 39.60 and Ultragenyx Pharmaceutical 200-day simple moving average is 42.46, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a Sell
The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.59B
Price in USD:
39.60
Share Volume:
766.32K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
54.56
52-Week Low:
31.52
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?
The Ultragenyx Pharmaceutical stock price is 39.60 USD today. -
Will RARE stock go up or go down?
Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Ultragenyx Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 39.60 while RARE 8-day exponential moving average is 39.76, which is a Sell signal.
- The stock price of RARE is 39.60 while Ultragenyx Pharmaceutical 20-day EMA is 40.54, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day exponential moving average is 42.03 while RARE share price is 39.60, making it a Sell technically.
- RARE stock price is 39.60 and Ultragenyx Pharmaceutical 200-day simple moving average is 43.46, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
- RARE Moving Average Covergence Divergence (MACD) indicator is -0.73, suggesting Ultragenyx Pharmaceutical is a Sell
- Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 45.77, which suggest Ultragenyx Pharmaceutical is oversold
- The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (38.99 - 42.29), which suggest Ultragenyx Pharmaceutical is a Sell
- The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (41.03 - 48.83), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.